Pharmaceutical Research and Manufacturers of America, more commonly known as PhRMA, spent more than double than the second-highest lobby. Most groups increased their spending efforts, and biotech Illumina nearly doubled its figure from $3.3 million to $6.1 million.
Here are the top 15, according to Politico:
|
Rank |
Organization |
2022 spending |
2021 spending |
|
1 |
Pharmaceutical Research and Manufacturers of America |
$28.3 million |
$29.6 million |
|
2 |
Pfizer |
$13.6 million |
$10.3 million |
|
3 |
Biotechnology Innovation Organization |
$13.3 million |
$13.3 million |
|
4 |
CVS Health |
$10.6 million |
$9.7 million |
|
5 |
Amgen |
$10.1 million |
$9.8 million |
|
6 |
Genentech |
$8.8 million |
$9.1 million |
|
7 |
Pharmaceutical Care Management Association |
$8.7 million |
$7.8 million |
|
8 |
Merck |
$8.3 million |
$8 million |
|
9 |
AbbVie |
$8.2 million |
$7 million |
|
10 |
Gilead Sciences |
$8 million |
$8.2 million |
|
11 |
Johnson & Johnson |
$7.8 million |
$6.1 million |
|
12 |
Eli Lilly |
$6.8 million |
$7 million |
|
13 |
Illumina |
$6.1 million |
$3.3 million |
|
14 |
Bayer |
$6 million |
$4.7 million |
|
15 |
Bristol Myers Squibb |
$5.4 million |
$5.4 million |
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
